Background The objective of this study is to estimate the incidence of genital warts in Hong
Kong and explore a way to establish a surveillance system for genital warts among the Hong …

The national cost of managing genital warts (GWs) in the UK has not been fully estimated,
yet is required to inform decisions on vaccination against human papillomavirus. This study …

Objective The study aimed to gauge the perceptions of Canadians toward genital warts,
related health behaviors, and treatment preferences. Materials and Methods An online …

Abstract Background The Human papillomavirus is the most common sexually transmitted
virus worldwide. The objective of this study was to estimate: 1) the prevalence and the …

Genital warts (GWs) caused by the human papilloma virus (HPV) are a significant health
problem due to high prevalence and rate of recurrence. Bivalent vaccine has been used …

[Anogenital warts incidence, medical management and costs in women consulting
gynaecologists in France]. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

Background A quadrivalent vaccine that prevents genital warts (GWs) has been
recommended by the Advisory Committee on Immunization Practices for women since 2007 …

Background Human papillomavirus (HPV) is a necessary cause of cervical cancer. HPV is
also responsible for benign condylomata acuminata, also known as genital warts. We …

Abstract Background In Italy the prevalence of genital warts in women (15–64 years) is
approximately 0.6% with an incidence of 0.4% per year. Treatments for GW are usually long …

The licensure of a vaccine against human papillomavirus (HPV) types 6, 11, 16, and 18
represents a major advance in the armamentarium for preventing cervical cancer, genital …